Cardioplegia Solution IV Bags Recalled for Sterility Assurance Deficiency
Central Admixture Pharmacy Services is recalling Cardioplegia Solution IV bags (Lot 36-257024) due to lack of sterility assurance and insufficient validation of decontamination processes. Healthcare providers should discontinue use immediately.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The product is classified as FDA Class II. While no illnesses or injuries have been reported, the lack of sterility assurance and inadequate validation of decontamination cycles in an intravenous cardiac medication represents a risk-of-harm product without yet-reported injury, meeting the criteria for High severity.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 48 bags of Cardioplegia Solution, IV Bag (Total Volume 1818 mL, Crystalloid Induction formulation, NDC 72196-0216-1, Lot 36-257024) that were distributed nationwide. The recall was initiated due to a lack of assurance of sterility and insufficient validation data for decontamination cycles.
Cardioplegia solution is administered intravenously during cardiac surgery to protect the heart during the procedure. The deficiencies in sterility assurance and decontamination validation create a potential risk of microbial contamination in the product.
Healthcare providers and hospitals that received the affected lot (36-257024, expiration 8/14/2023) should immediately discontinue use and contact Central Admixture Pharmacy Services, Inc. at their facility in Phoenix, Arizona for instructions on product return or replacement. Any adverse events associated with use of this product should be reported to the FDA.
The recalled product
- Product
- CARDIOPLEGIA SOLUTION, IV Bag, Total Volume = 1818 mL, CRYSTALLOID INDUCTION, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0216-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Intravenous / Surgical
- Affected units
- 48
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 36-257024
- Exp. 8/14/2023.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 95 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 95 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · sterility
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29